IFG Advisory
VRTX icon

IFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

IFG Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14M Buy
2,187
+246
+13% +$126K 0.04% 414
2026
Q2 		$964K Buy
+1,941
New +$860K 0.03% 435
2026
Q1 		– Sell
-1,941
Closed -$880K – 864
2025
Q4 		$880K Hold
1,941
– – 0.04% 393
2025
Q3 		$760K Sell
1,941
-44
-2% -$18.4K 0.03% 411
2025
Q2 		$884K Buy
1,985
+3
+0.2% +$1.38K 0.04% 378
2025
Q1 		$961K Hold
1,982
– – 0.05% 333
2024
Q4 		$798K Buy
+1,982
New +$919K 0.05% 332
2024
Q3 		– Sell
-2,181
Closed -$1.02M – 620
2024
Q2 		$1.02M Buy
+2,181
New +$947K 0.07% 273
2024
Q1 		– Sell
-2,319
Closed -$944K – 583
2023
Q4 		$944K Buy
2,319
+14
+0.6% +$5.17K 0.07% 252
2023
Q3 		$802K Buy
+2,305
New +$806K 0.07% 257
2023
Q2 		– Sell
-2,342
Closed -$738K – 503
2023
Q1 		$738K Sell
2,342
-20
-0.8% -$6K 0.07% 255
2022
Q4 		$682K Buy
2,362
+29
+1% +$8.84K 0.07% 265
2022
Q3 		$675K Buy
+2,333
New +$671K 0.06% 274
2019
Q3 		– Sell
-2,264
Closed -$415K – 452
2019
Q2 		$415K Buy
2,264
+47
+2% +$8.22K 0.07% 226
2019
Q1 		$407K Sell
2,217
-158
-7% -$29.2K 0.08% 221
2018
Q4 		$393K Buy
2,375
+2
+0.1% +$347 0.09% 210
2018
Q3 		$457K Sell
2,373
-12
-0.5% -$2.14K 0.09% 226
2018
Q2 		$405K Buy
2,385
+142
+6% +$22K 0.08% 228
2018
Q1 		$365K Sell
2,243
-5
-0.2% -$817 0.08% 233
2017
Q4 		$336K Buy
+2,248
New +$333K 0.08% 243

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFG Advisory's VRTX Position: Q3 2026 in Review

IFG Advisory increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q3 2026, buying an estimated $126K and bringing the position to 2,187 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #414.

IFG Advisory first reported a position in VRTX in Q4 2017 and has held it in 20 quarters since. 1,069 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • IFG Advisory held 2,187 shares of Vertex Pharmaceuticals worth $1.14M as of Q3 2026.
  • IFG Advisory bought 246 Vertex Pharmaceuticals shares in Q3 2026, an estimated $126K.
  • Vertex Pharmaceuticals made up 0.04% of IFG Advisory's portfolio in Q3 2026, its #414 holding.
  • IFG Advisory first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • 1,069 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.